Sunstone Hotel Investors Stock News

SHO earnings call for the period ending March 31, 2022.

Sunstone Hotel (SHO) delivered FFO and revenue surprises of 14.29% and 11.53%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IRVINE, Calif. , April 6, 2022 /PRNewswire/ -- Sunstone Hotel Investors, Inc. (the "Company" or "Sunstone") (NYSE: SHO), the owner of Long-Term Relevant Real Estate® in the lodging industry, announce

Sunstone Hotel (SHO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa

Sunstone Hotel Investors (SHO) board appointed Bryan Giglia, current CFO, as its CEO, effective immediately.The board also appointed Robert Springer, Chief Investment Officer, to…

In the past, I had been rather bullish about the prospects of Sunstone Hotel Investors based on the opportunity for its operations to turn around.

Wednesday''s top analyst upgrades and downgrades included Allstate, Arista Networks, Comcast, DraftKings, GoodRx, Kroger, Live Nation Entertainment, Luminar Technologies, Snap, Sunstone Hotel Investors, Twitter, Voya Financial, Vroom, Waste Management, Workday, Zoom Video Communications.

Barclays analyst Anthony Powell downgraded Sunstone Hotel Investors (SHO) to Underweight from Overweight as the analyst''s thesis that the hotel REIT would achieve better external…

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.

SHO earnings call for the period ending December 31, 2021.

SHO earnings call for the period ending December 31, 2021.

Sunstone Hotel Investors, Inc. (SHO) CEO Doug Pasquale on Q4 2021 Results - Earnings Call Transcript

Sunstone Hotel (SHO) delivered FFO and revenue surprises of -27.27% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?